The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALKERMES PLC | SHS | G01767105 | 243,120 | 6,000 | SH | SOLE | 0 | 0 | 6,000 | ||
| ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 264,300 | 10,000 | SH | SOLE | 0 | 0 | 10,000 | ||
| ARDELYX INC | COM | 039697107 | 102,600 | 30,000 | SH | SOLE | 0 | 0 | 30,000 | ||
| ARGENX SE | SPONSORED ADR | 04016X101 | 287,673 | 300 | SH | SOLE | 0 | 0 | 300 | ||
| ASCENDIS PHARMA A/S | ORD SHS | K08588103 | 227,830 | 1,000 | SH | SOLE | 0 | 0 | 1,000 | ||
| AURINIA PHARMACEUTICALS INC | COM | 05156V102 | 242,925 | 15,000 | SH | SOLE | 0 | 0 | 15,000 | ||
| COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | 124,400 | 10,000 | SH | SOLE | 0 | 0 | 10,000 | ||
| CYTOMX THERAPEUTICS INC. | COM | 23284F105 | 107,168 | 39,400 | SH | SOLE | 0 | 0 | 39,400 | ||
| DEFINIUM THERAPEUTICS INC | COM SHS | 24477V105 | 247,390 | 6,500 | SH | SOLE | 0 | 0 | 6,500 | ||
| DIANTHUS THERAPEUTICS INC | COM | 252828108 | 220,125 | 2,500 | SH | SOLE | 0 | 0 | 2,500 | ||
| DYNE THERAPEUTICS INC | COM | 26818M108 | 161,100 | 10,000 | SH | SOLE | 0 | 0 | 10,000 | ||
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 203,000 | 5,000 | SH | SOLE | 0 | 0 | 5,000 | ||
| EXELIXIS INC | COM | 30161Q104 | 292,050 | 5,000 | SH | SOLE | 0 | 0 | 5,000 | ||
| HALOZYME THERAPEUTICS INC | COM | 40637H109 | 331,200 | 3,000 | SH | SOLE | 0 | 0 | 3,000 | ||
| HARMONY BIOSCIENCES HLDGS IN | COM | 413197104 | 274,820 | 7,000 | SH | SOLE | 0 | 0 | 7,000 | ||
| IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 212,030 | 7,000 | SH | SOLE | 0 | 0 | 7,000 | ||
| IMMUNOME INC | COM | 45257U108 | 258,120 | 12,000 | SH | SOLE | 0 | 0 | 12,000 | ||
| IMMUNOVANT INC | COM | 45258J102 | 236,460 | 7,000 | SH | SOLE | 0 | 0 | 7,000 | ||
| INCYTE CORP | COM | 45337C102 | 242,700 | 2,000 | SH | SOLE | 0 | 0 | 2,000 | ||
| INTELLIA THERAPEUTICS INC | COM | 45826J105 | 241,200 | 20,000 | SH | SOLE | 0 | 0 | 20,000 | ||
| ISHARES TR | 0-3 MTH TREASURY | 46436E718 | 70,476,000 | 700,000 | SH | SOLE | 0 | 0 | 700,000 | ||
| KINIKSA PHARMACEUTICALS INTL | ORD SHS CL A | G52694109 | 261,135 | 3,500 | SH | SOLE | 0 | 0 | 3,500 | ||
| KRYSTAL BIOTECH INC | COM | 501147102 | 230,132 | 692 | SH | SOLE | 0 | 0 | 692 | ||
| KYMERA THERAPEUTICS INC | COM | 501575104 | 223,580 | 2,000 | SH | SOLE | 0 | 0 | 2,000 | ||
| MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 302,376 | 600 | SH | SOLE | 0 | 0 | 600 | ||
| MIRUM PHARMACEUTICALS INC | COM | 604749101 | 213,700 | 2,500 | SH | SOLE | 0 | 0 | 2,500 | ||
| NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 255,312 | 1,800 | SH | SOLE | 0 | 0 | 1,800 | ||
| NURIX THERAPEUTICS INC | COM | 67080M103 | 284,520 | 12,000 | SH | SOLE | 0 | 0 | 12,000 | ||
| OCULAR THERAPEUTIX INC | COM | 67576A100 | 115,050 | 15,000 | SH | SOLE | 0 | 0 | 15,000 | ||
| OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 86,400 | 10,000 | SH | SOLE | 0 | 0 | 10,000 | ||
| ORIC PHARMACEUTICALS INC | COM | 68622P109 | 175,110 | 13,000 | SH | SOLE | 0 | 0 | 13,000 | ||
| ORUKA THERAPEUTICS INC | COM | 687604108 | 249,870 | 3,000 | SH | SOLE | 0 | 0 | 3,000 | ||
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 211,335 | 1,500 | SH | SOLE | 0 | 0 | 1,500 | ||
| REVOLUTION MEDICINES INC | COM | 76155X100 | 246,312 | 1,200 | SH | SOLE | 0 | 0 | 1,200 | ||
| ROYALTY PHARMA PLC | SHS CLASS A | G7709Q104 | 291,800 | 5,000 | SH | SOLE | 0 | 0 | 5,000 | ||
| SERA PROGNOSTICS INC | CLASS A COM | 81749D107 | 5,009,072 | 2,396,685 | SH | SOLE | 0 | 0 | 2,396,685 | ||
| SPDR SERIES TRUST | ST STR SP BIOT | 78464A870 | 60,943,320 | 386,500 | SH | SOLE | 0 | 0 | 386,500 | ||
| STOKE THERAPEUTICS INC | COM | 86150R107 | 234,000 | 9,000 | SH | SOLE | 0 | 0 | 9,000 | ||
| SUPERNUS PHARMACEUTICALS | COM | 868459108 | 258,240 | 6,000 | SH | SOLE | 0 | 0 | 6,000 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 225,600 | 12,000 | SH | SOLE | 0 | 0 | 12,000 | ||
| TANGO THERAPEUTICS INC | COM | 87583X109 | 249,500 | 10,000 | SH | SOLE | 0 | 0 | 10,000 | ||
| TARSUS PHARMACEUTICALS INC | COM | 87650L103 | 275,135 | 3,500 | SH | SOLE | 0 | 0 | 3,500 | ||
| TG THERAPEUTICS INC | COM | 88322Q108 | 278,900 | 5,000 | SH | SOLE | 0 | 0 | 5,000 | ||
| TREVI THERAPEUTICS INC | COM | 89532M101 | 214,800 | 15,000 | SH | SOLE | 0 | 0 | 15,000 | ||